Elucidating the nociceptive role of CGRP in migraine headache
Abstract
Calcitonin gene-related peptide (CGRP) is thought to be a key player in the pathogenesis of migraine, but there is a fundamental mystery in that the known neuronal actions of CGRP do not account for how it causes pain. We now report the first finding of CGRP-induced nociceptive neuronal activation using a novel method of intra-carotid infusion to achieve a more targeted delivery to cranial tissues. Single-unit recordings were performed in anaesthetized rats to measure CGRP effects on first- and second-order trigeminovascular neurons. CGRP was administered via intra-carotid infusion. Neuronal activation and sensitization were assessed by spontaneous firing rates and responses to mechanical stimulation of dural and facial receptive fields. Lidocaine was applied locally to the dura or trigeminal ganglion at varying time points to determine the peripheral contribution to CGRP-induced activity. Intra-carotid CGRP infusion (5 µg/kg/min, 20 min) activated 62% of Aδ-fibres and 56% of C-fibres, with significant increases in firing rates beginning within the first 30 min for Aδ-fibres and after 1 h for C-fibres. It also activated 75% of central trigeminovascular neurons, significantly increasing spontaneous firing and sensitizing dural and facial receptive fields. Similar effects were produced by CGRP injection into the trigeminal ganglion. These effects of CGRP were impeded by local anaesthetic blockade of the dura or trigeminal ganglion before but not 1 h after CGRP infusion. No…
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.